Susquehanna International Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.62M Buy
39,176
+36,237
+1,233% +$5.06M ﹤0.01% 4372
2025
Q4
$482K Sell
2,939
-34,406
-92% -$5.39M ﹤0.01% 8878
2025
Q3
$4.99M Sell
37,345
-21,676
-37% -$2.63M ﹤0.01% 4093
2025
Q2
$7.34M Buy
59,021
+20,292
+52% +$2.58M ﹤0.01% 3302
2025
Q1
$4.93M Buy
38,729
+14,948
+63% +$2.3M ﹤0.01% 3680
2024
Q4
$3.42M Sell
23,781
-25,669
-52% -$3.68M ﹤0.01% 4211
2024
Q3
$7.36M Buy
49,450
+30,307
+158% +$4.35M ﹤0.01% 3024
2024
Q2
$2.41M Buy
+19,143
New +$3M ﹤0.01% 4724
2024
Q1
Sell
-7,601
Closed -$1.45M 13157
2023
Q4
$1.37M Sell
7,601
-614
-7% -$95.6K ﹤0.01% 6210
2023
Q3
$1.31M Sell
8,215
-44,257
-84% -$7.23M ﹤0.01% 6029
2023
Q2
$7.42M Buy
52,472
+33,284
+173% +$5.34M ﹤0.01% 2909
2023
Q1
$3.23M Buy
19,188
+16,220
+546% +$2.89M ﹤0.01% 4180
2022
Q4
$503K Sell
2,968
-9,776
-77% -$1.77M ﹤0.01% 7862
2022
Q3
$2.38M Sell
12,744
-18,128
-59% -$3.82M ﹤0.01% 4573
2022
Q2
$5.01M Buy
30,872
+22,595
+273% +$3.57M ﹤0.01% 3184
2022
Q1
$1.56M Buy
8,277
+6,534
+375% +$1.24M ﹤0.01% 6041
2021
Q4
$462K Buy
1,743
+864
+98% +$233K ﹤0.01% 9421
2021
Q3
$254K Sell
879
-15,757
-95% -$4.04M ﹤0.01% 10978
2021
Q2
$3.32M Sell
16,636
-39,165
-70% -$7.6M ﹤0.01% 4803
2021
Q1
$10.8M Sell
55,801
-316
-0.6% -$64.8K ﹤0.01% 2649
2020
Q4
$10.8M Sell
56,117
-28,380
-34% -$5.16M ﹤0.01% 2411
2020
Q3
$12.5M Buy
84,497
+51,895
+159% +$7.42M ﹤0.01% 1951
2020
Q2
$4.03M Sell
32,602
-19,643
-38% -$2.31M ﹤0.01% 3313
2020
Q1
$5.04M Sell
52,245
-15,546
-23% -$1.5M ﹤0.01% 2558
2019
Q4
$6.27M Sell
67,791
-147,176
-68% -$12.4M ﹤0.01% 2661
2019
Q3
$16.5M Buy
214,967
+179,103
+499% +$15.7M 0.01% 1495
2019
Q2
$3.08M Buy
+35,864
New +$2.44M ﹤0.01% 3402
2019
Q1
Sell
-30,662
Closed -$1.76M 9670
2018
Q4
$1.62M Buy
+30,662
New +$1.8M ﹤0.01% 3846
2017
Q3
Sell
-21,037
Closed -$882K 9489
2017
Q2
$872K Buy
+21,037
New +$799K ﹤0.01% 5551
2016
Q1
Sell
-37,847
Closed -$926K 9548
2015
Q4
$1.07M Buy
37,847
+1,418
+4% +$40.9K ﹤0.01% 5274
2015
Q3
$1.01M Sell
36,429
-9,713
-21% -$351K ﹤0.01% 5714
2015
Q2
$1.9M Buy
+46,142
New +$1.69M ﹤0.01% 4819
2015
Q1
Sell
-75,443
Closed -$1.96M 9849
2014
Q4
$1.49M Buy
+75,443
New +$1.69M ﹤0.01% 5047
2014
Q3
Sell
-20,186
Closed -$425K 9852
2014
Q2
$460K Buy
+20,186
New +$359K ﹤0.01% 7634
2013
Q4
Sell
-39,699
Closed -$474K 9262
2013
Q3
$440K Buy
+39,699
New +$395K ﹤0.01% 6617

Other funds holding RGEN

Susquehanna International Group's RGEN Position: Q1 2026 in Review

Susquehanna International Group increased its Repligen (RGEN) stake by 1,233% in Q1 2026, buying an estimated $5.06M and bringing the position to 39,176 shares worth $4.62M. The position accounts for ﹤0.01% of the portfolio, ranked #4372.

Susquehanna International Group first reported a position in RGEN in Q3 2013 and has held it in 35 quarters since. The position peaked at $16.5M in Q3 2019. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Susquehanna International Group held 39,176 shares of Repligen worth $4.62M as of Q1 2026.
  • Susquehanna International Group bought 36,237 Repligen shares in Q1 2026, an estimated $5.06M.
  • Repligen made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4372 holding.
  • Susquehanna International Group first reported a position in Repligen in Q3 2013 and has held it in 35 quarters since.
  • Susquehanna International Group's Repligen position peaked at $16.5M in Q3 2019.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.